Karen Lewis Apellis Pharmaceuticals, Inc. (APLS) insider trading activity

APLS Quotes by TradingView

Karen Lewis is Chief People Officer of Apellis Pharmaceuticals, Inc.. Currently has a direct ownership of 70,251 shares of APLS, which is worth approximately $2.04 Million. The most recent transaction as insider was on Jan 28, 2022, when has been sold 434 shares (Common Stock) at a price of $38.59 per share, resulting in proceeds of $16,748. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 70.3K
51.45% 3M change
51.45% 12M change
Total Value Held $2.04 Million

Karen Lewis Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 28 2022
SELL
Payment of exercise price or tax liability
$16,748 $38.59 p/Share
434 Reduced 1.82%
23,474 Common Stock
Jan 21 2022
BUY
Grant, award, or other acquisition
-
17,466 Added 42.21%
23,908 Common Stock
Jan 28 2021
BUY
Grant, award, or other acquisition
-
6,250 Added 50.0%
6,250 Common Stock
KL

Karen Lewis

Chief People Officer
Waltham, MA

Track Institutional and Insider Activities on APLS

Follow Apellis Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells APLS shares.

Notify only if

Insider Trading

Get notified when an Apellis Pharmaceuticals, Inc. insider buys or sells APLS shares.

Notify only if

News

Receive news related to Apellis Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on APLS